The utility of an antifos ribozyme in reversing cisplatin resistance in human carcinomas
- 31 December 1992
- journal article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 32, 195-209
- https://doi.org/10.1016/0065-2571(92)90017-t
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracilEuropean Journal of Cancer and Clinical Oncology, 1990
- Growth Factors Regulate Transin Gene Expression by c- fos -Dependent and c- fos -Independent PathwaysScience, 1988
- Fos and jun: The AP-1 connectionCell, 1988
- Overexpression of Metallothionein Confers Resistance to Anticancer DrugsScience, 1988
- Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol estersCell, 1988
- Common DNA binding site for Fos protein complexesand transcription factor AP-1Cell, 1988
- Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factorCell, 1987
- BIOLOGICAL CATALYSIS BY RNAAnnual Review of Biochemistry, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogeneNature, 1984